Announcement on the resignation of the Company's
institutional director
Date of events
2022/03/07
To which item it meets
paragraph 6
Statement
1.Date of occurrence of the change:2022/03/07
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):institutional director
3.Title and name of the previous position holder:Microbio Co., Ltd. and
representative
4.Resume of the previous position holder:The company's institutional
director/Chairman of Microbio Co., Ltd.
5.Title and name of the new position holder:None
6.Resume of the new position holder:None
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"):resignation
8.Reason for the change:resignation
9.Number of shares held by the new position holder when elected:NA
10.Original term (from __________ to __________):2021/08/18 ~ 2024/08/17
11.Effective date of the new appointment:NA
12.Turnover rate of directors of the same term:1/7
13.Turnover rate of independent directors of the same term:NA
14.Turnover rate of supervisors of the same term:NA
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):No
16.Any other matters that need to be specified:
Microbio Co., Ltd. currently has two representation directors in Oneness.
For corporate governance considerations, one of the institutional
directors of the Company has decided to resign with effective date on
2022/05/24. A by-election agenda will be proposed for the 2022
shareholders meeting during the Board meeting on 2022/03/15.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Oneness Biotech Co Ltd. published this content on 07 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 March 2022 11:59:09 UTC.
ONENESS BIOTECH CO., LTD. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include health supplies, health food and healthy food. The Company is also involved in the development of new drugs for the treatment of wound healing in chronic diabetic foot ulcers, as well as the development of new anticancer drugs. The Company distributes its products in domestic market.
ONENESS BIOTECH CO., LTD. 
